The crystal structure is shown in the figure. Tables 1 and 2 contain details on crystal structure and measurement conditions and a list of the atoms including atomic coordinates and displacement parameters. 
T = 293(2) K.
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The crystal structure is shown in the figure. Tables 1 and 2 contain details on crystal structure and measurement conditions and a list of the atoms including atomic coordinates and displacement parameters. Source of material
5]decan-4-one (1.8 g, 0.0047 mol) in toluene (40 mL) was added morpholine (2.0 g, 0.023 mol). The mixture was heated at 90°C overnight, cooled to room temperature and solvent was evaporated under reduced pressure. The obtained buff solid was dissolved in methylene chloride (100 mL) and washed two times with water. The organic phase was separated, dried (Na 2 SO4) and evaporated under vacuum to furnish the title compound as a white solid. The crude product was re-crystallized from a mixture of petroleum ether (40-60) and ethyl acetate to afford white crystals (m.p. 441-443 K) in 60% yield [1] . Crystals were obtained by slow evaporation of its ethyl acetate solution. 
Experimental details
H atoms were placed in calculated positions and were included in the refinement in the riding model approximation, with U iso (H) set to 1.2Ueq(C).
Discussion
Epilepsy is a prevalent neurological disturbance recognized by persistent unprovoked seizures that affects about 50 million individual all over the world [2] . In the past few decades, a number of new antiepileptic drugs have been emerged to the market. Nevertheless, approximately 30% of the patients don't repay to the available antiepileptic medications [3] . In addition, long term administration of the currently used antiepileptics is accompanied by unfavourable side effects like megaloblastic anaemia and hepatotoxicity [4, 5] . Accordingly, the search for new antiepileptic agents endowed with high potency and better safety profile has gained a considerable attention. The title molecule, displayed a good anticonvulsant activity (83% protection) against subcutaneous pentylenetetrazole induced convulsions at dose level 0.025 mmol/kg. Whereas, it exhibited mild anticonvulsant activity (66% protection) against maximal electric shock induced convulsions, at the same dose level [1] . The asymmetric unit of the title compound contains one molecule. The morpholine and cyclohexan moieties adopt the usual chair conformation. The imidazolidinyl (C1/N1/C2/C3/N2) unit makes dihedral angles of 85.43°and 43.42°with the planes of the phenyl rings (C9-C14) and (C15-C20), respectively.
